glp 1 winner From You never know until you

For many patients, these medications are helping to achieve significant weight loss and improvements in overall health

(1) (2) This peptide mimics GLP-1 but lasts much longer in the body, making it a valuable blueprint for modern medications

A significant contributing factor to the prevalence of T2DM is obesity, which is strongly associated with serious consequences such as chronic kidney disease, hypertension, stroke, and liver disease that impair both the quality and quantity of life as life expectancy declines with rising body mass index (BMI) [2]

As Raciti puts it, Protein powders offer the most flexibility

This means companies can market products as GLP-1 mimetics or fat burners without providing scientific evidence, and without going through rigorous testing for safety or efficacy

January 2017 Volume 40, Supplement 1